Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q3 2016 13F Holders as of 30 Sep 2016
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 4,238,270
- Share change
- -2,832,423
- Total reported value
- $12,814,000
- Price per share
- $3.01
- Number of holders
- 14
- Value change
- -$8,129,564
- Number of buys
- 10
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05156V102:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.8%
|
2,457,144
|
$7,192,000 | — | 30 Jun 2016 | |
| NEA Management Company, LLC |
13F
|
Company |
1.9%
|
2,546,843
|
$7,055,000 | — | 30 Jun 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.54%
|
711,499
|
$2,120,000 | — | 30 Jun 2016 | |
| EverPoint Asset Management, LLC |
13F
|
Company |
0.45%
|
600,000
|
$1,662,000 | — | 30 Jun 2016 | |
| Abingworth LLP |
13F
|
Company |
0.39%
|
512,036
|
$1,388,000 | — | 30 Jun 2016 | |
| Lombard Odier Asset Management (USA) Corp |
13F
|
Company |
0.08%
|
102,294
|
$283,000 | — | 30 Jun 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
50,000
|
$139,000 | — | 30 Jun 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
41,100
|
$114,000 | — | 30 Jun 2016 | |
| Redmile Group, LLC |
13F
|
Company |
0.02%
|
28,410
|
$79,000 | — | 30 Jun 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
10,768
|
$30,000 | — | 30 Jun 2016 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
7,500
|
$21,000 | — | 30 Jun 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,099
|
$6,000 | — | 30 Jun 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 30 Jun 2016 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2016
As of 30 Sep 2016,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,238,270 shares.
The largest 10 holders included
NEA Management Company, LLC, Abingworth LLP, GOLDMAN SACHS GROUP INC, SG Americas Securities, LLC, Redmile Group, LLC, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Creative Planning, KCG Holdings, Inc., and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
13
Q3 2016 holders
14
Holder diff
1
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.